Net profit of Kilitch Drugs (India) rose 189.69% to Rs 10.40 crore in the quarter ended March 2025 as against Rs 3.59 crore during the previous quarter ended March 2024. Sales rose 36.61% to Rs 61.23 crore in the quarter ended March 2025 as against Rs 44.82 crore during the previous quarter ended March 2024.
For the full year,net profit rose 82.88% to Rs 26.70 crore in the year ended March 2025 as against Rs 14.60 crore during the previous year ended March 2024. Sales rose 28.47% to Rs 198.32 crore in the year ended March 2025 as against Rs 154.37 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 61.23 | 44.82 | 37 | 198.32 | 154.37 | 28 |
| OPM % | 23.83 | 15.80 | - | 15.87 | 15.64 | - |
| PBDT | 14.69 | 6.23 | 136 | 37.58 | 22.70 | 66 |
| PBT | 13.84 | 5.30 | 161 | 34.47 | 19.35 | 78 |
| NP | 10.40 | 3.59 | 190 | 26.70 | 14.60 | 83 |